Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment.
Rohit GuptaR A SimonetteH Q DoanP L RadyS K TyringPublished in: The British journal of dermatology (2021)